These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16601680)

  • 1. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.
    Tréand C; du Chéné I; Brès V; Kiernan R; Benarous R; Benkirane M; Emiliani S
    EMBO J; 2006 Apr; 25(8):1690-9. PubMed ID: 16601680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter.
    Mahmoudi T; Parra M; Vries RG; Kauder SE; Verrijzer CP; Ott M; Verdin E
    J Biol Chem; 2006 Jul; 281(29):19960-8. PubMed ID: 16687403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts.
    Mizutani T; Ishizaka A; Tomizawa M; Okazaki T; Yamamichi N; Kawana-Tachikawa A; Iwamoto A; Iba H
    J Virol; 2009 Nov; 83(22):11569-80. PubMed ID: 19726504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.
    He G; Margolis DM
    Mol Cell Biol; 2002 May; 22(9):2965-73. PubMed ID: 11940654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.
    Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T
    PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
    El Kharroubi A; Piras G; Zensen R; Martin MA
    Mol Cell Biol; 1998 May; 18(5):2535-44. PubMed ID: 9566873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
    Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
    J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
    Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat.
    Liu YZ; Latchman DS
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):155-8. PubMed ID: 9078256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNFing HIV transcription.
    Bukrinsky M
    Retrovirology; 2006 Aug; 3():49. PubMed ID: 16899112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.
    Brès V; Kiernan RE; Linares LK; Chable-Bessia C; Plechakova O; Tréand C; Emiliani S; Peloponese JM; Jeang KT; Coux O; Scheffner M; Benkirane M
    Nat Cell Biol; 2003 Aug; 5(8):754-61. PubMed ID: 12883554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions.
    Rampalli S; Kulkarni A; Kumar P; Mogare D; Galande S; Mitra D; Chattopadhyay S
    Nucleic Acids Res; 2003 Jun; 31(12):3248-56. PubMed ID: 12799452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin remodeling and modification during HIV-1 Tat-activated transcription.
    Pumfery A; Deng L; Maddukuri A; de la Fuente C; Li H; Wade JD; Lambert P; Kumar A; Kashanchi F
    Curr HIV Res; 2003 Jul; 1(3):343-62. PubMed ID: 15046258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.